These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 6299815)
21. The Renin-Angiotensin-Aldosterone System in Greyhounds and Non-Greyhound Dogs. Martinez J; Kellogg C; Iazbik MC; Couto CG; Pressler BM; Hoepf TM; Radin MJ J Vet Intern Med; 2017 Jul; 31(4):988-993. PubMed ID: 28488321 [TBL] [Abstract][Full Text] [Related]
22. Effects of aqueous extract of Hibiscus sabdariffa on the renin-angiotensin-aldosterone system of Nigerians with mild to moderate essential hypertension: A comparative study with lisinopril. Nwachukwu DC; Aneke EI; Obika LF; Nwachukwu NZ Indian J Pharmacol; 2015; 47(5):540-5. PubMed ID: 26600645 [TBL] [Abstract][Full Text] [Related]
23. Increased urine angiotensin I converting enzyme activity in patients with upper urinary tract infection. Baggio B; Favaro S; Cantaro S; Bertazzo L; Frunzio A; Borsatti A Clin Chim Acta; 1981 Jan; 109(2):211-8. PubMed ID: 6258828 [TBL] [Abstract][Full Text] [Related]
24. The intrarenal generation of angiotensin II is required for experimental hypertension. Giani JF; Shah KH; Khan Z; Bernstein EA; Shen XZ; McDonough AA; Gonzalez-Villalobos RA; Bernstein KE Curr Opin Pharmacol; 2015 Apr; 21():73-81. PubMed ID: 25616034 [TBL] [Abstract][Full Text] [Related]
25. Effect of angiotensin blockade and converting enzyme inhibition on renovascular hypertension: comparison between unilateral and bilateral renal artery stenosis. Takabatake T; Ohta H; Yamamoto Y; Ishida Y; Hara H; Ushiogi Y; Nakamura S; Hattori N Angiology; 1987 Jun; 38(6):434-9. PubMed ID: 3035964 [TBL] [Abstract][Full Text] [Related]
26. Serum angiotensin converting enzyme activity in normal adults and patients with different types of hypertension. Dux S; Aron N; Boner G; Carmel A; Yaron A; Rosenfeld JB Isr J Med Sci; 1984 Dec; 20(12):1138-42. PubMed ID: 6097566 [TBL] [Abstract][Full Text] [Related]
28. [The effect of alterations of the renin-angiotensin system and the sympathetic nervous system on plasma bradykinin concentration in patients with essential hypertension]. Takeda Y Nihon Naibunpi Gakkai Zasshi; 1984 Sep; 60(9):1112-24. PubMed ID: 6097486 [TBL] [Abstract][Full Text] [Related]
29. The impaired control of plasma renin activity in hypertensive patients with end-stage renal disease due to chronic glomerulonephritis. Yasuda G; Nagasawa T; Umemura S; Shionoiri H; Ishii M Clin Nephrol; 1994 Nov; 42(5):300-8. PubMed ID: 7851031 [TBL] [Abstract][Full Text] [Related]
30. Dopaminergic control of aldosterone secretion in hypertensive patients chronically treated with an angiotensin converting enzyme inhibitor. Waeber B; Nussberger J; Schaller MD; Gomez HJ; Brunner HR Horm Metab Res; 1986 Jan; 18(1):60-3. PubMed ID: 3005150 [TBL] [Abstract][Full Text] [Related]
31. Effects of aldosterone and angiotensin II receptor blockade on cardiac angiotensinogen and angiotensin-converting enzyme 2 expression in Dahl salt-sensitive hypertensive rats. Takeda Y; Zhu A; Yoneda T; Usukura M; Takata H; Yamagishi M Am J Hypertens; 2007 Oct; 20(10):1119-24. PubMed ID: 17903697 [TBL] [Abstract][Full Text] [Related]
32. Relation between the renin-angiotensin-aldosterone system and left ventricular structure and function in young normotensive and mildly hypertensive subjects. Schlaich MP; Klingbeil A; Hilgers K; Schobel HP; Schmieder RE Am Heart J; 1999 Nov; 138(5 Pt 1):810-7. PubMed ID: 10539810 [TBL] [Abstract][Full Text] [Related]
33. Effects of a single administration of captopril on hemodynamics and serum angiotensin converting enzyme activity, plasma renin activity and plasma aldosterone concentration in hypertensive patients. Hashimoto H; Hiwada K; Kokubu T Jpn Circ J; 1981 Feb; 45(2):176-80. PubMed ID: 6262543 [TBL] [Abstract][Full Text] [Related]
34. Report on the fifth annual Laragh conference: Interaction of the angiotensin converting enzyme (ACE) with the renin-angiotensin system, the kinin system and beyond. Gavras H Am J Hypertens; 2005 Jan; 18(1):1-2. PubMed ID: 15691609 [No Abstract] [Full Text] [Related]
35. [Renin-angiotensin-aldosterone system in thyroid disorders]. Marcisz C Postepy Hig Med Dosw; 2000; 54(4):519-35. PubMed ID: 11016270 [TBL] [Abstract][Full Text] [Related]
36. Aldosterone synthase -344C/T and angiotensin-converting enzyme I/D polymorphisms in Turkish hypertensive patients with normal coronary arteries. Olcay A; Nisanci Y; Ekmekci CG; Umman B; Bugra Z; Sezer M; Acar RD; Ozbek U Acta Cardiol; 2006 Feb; 61(1):29-34. PubMed ID: 16485730 [TBL] [Abstract][Full Text] [Related]
37. Novel therapies blocking the renin-angiotensin-aldosterone system in the management of hypertension and related disorders. Krum H; Gilbert RE J Hypertens; 2007 Jan; 25(1):25-35. PubMed ID: 17143168 [TBL] [Abstract][Full Text] [Related]
38. New aspects of the renin-angiotensin system: angiotensin-converting enzyme 2 - a potential target for treatment of hypertension and diabetic nephropathy. Batlle D; Soler MJ; Wysocki J Curr Opin Nephrol Hypertens; 2008 May; 17(3):250-7. PubMed ID: 18408475 [TBL] [Abstract][Full Text] [Related]
39. Effects of angiotensin I converting enzyme inhibitor (SQ 14,225) on the responses of blood pressure and steroid hormone to angiotensin II and ACTH infusion in hypertensive subjects. Ueda Y; Honda M; Hatano M Jpn Circ J; 1982 Mar; 46(3):267-73. PubMed ID: 6278173 [TBL] [Abstract][Full Text] [Related]